Treatment options to intensify hemodialysis

Kidney and Blood Pressure Research

Volumn 26, Issue 2, 2003, Pages 90-95

  Haag Weber, Marianne ^a  

^a Urologische Klinik   (Germany)

Author keywords

Hemodialysis, 8 h 3 times week; Middle molecule; Mortality; Nocturnal hemodialysis; Phosphate; Short daily hemodialysis

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA 2 MICROGLOBULIN; ERYTHROPOIETIN; PHOSPHATE; PHOSPHATE BINDING AGENT; SODIUM; UREA;

ANEMIA; ARTERIOVENOUS FISTULA; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BONE DISEASE; COMORBIDITY; DIALYSIS; EXTRACELLULAR SPACE; HEMODIALYSIS; HUMAN; JAPAN; KIDNEY FUNCTION; MEDICARE; MOLECULAR BIOLOGY; NUTRITION; NUTRITIONAL STATUS; PHOSPHATE METABOLISM; PRIORITY JOURNAL; QUALITY OF LIFE; REGISTER; REVIEW; SLEEP; SODIUM RESTRICTION; SURVIVAL; TIME; TREATMENT CONTRAINDICATION; UNITED STATES;

APPOINTMENTS AND SCHEDULES; HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC; QUALITY OF LIFE; RENAL DIALYSIS;

EID: 0038549059     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070989     Document Type: Review

References (28)

1. Wolfe RA, Held PJ, Hulbert-Shearon TE, Agodoa LYC, Port FK: A critical examination of trends in outcomes over the last decade. Am J Kidney Dis 1998;32(suppl 4):9-15.
2. Hull AR: The 1989 morbidity and mortality meeting: How far have we come? Am J Kidney Dis 1998;32(suppl 4):6-8.
3. Lebedo I, Lameire N, Charra B, Locatelli F, Kooistra M, Kessler M, Jacobs J: Improving the outcome of dialysis - Opinion vs. scientific evidence. Nephrol Dial Transplant 2000;15:1310-1316.
4. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286-1291.
5. Laurent G, Charra B: The results of an 8 h thrice weekly hemodialysis schedule. Nephrol Dial Transplant 1998;13(suppl 6):125-131.
6. Charra B, Laurent G, Chazot C, Jean G, Terrat JC, Vanel T: Hemodialysis trends in time, 1989-1998, independent of dose and outcome. Am J Kidney Dis 1998;32(suppl 4):63-70.
7. Katzarski KS, Charra B, Luik AJ, Nisell J, Div-ino Filho JC, Leypoldt JK, Leunissen KM, Laurent G, Bergström J: Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 1999;14:369-375.
8. Luik AJ, van der Sande FM, Weideman P, Cheriex E, Kooman JP, Leunissen KML: The influence of increasing dialysis treatment time and reducing weight on blood pressure control in hemodialysis patients: A prospective study. Am J Nephrol 2001;21:471-478.
9. Pierratos A: Daily hemodialysis: Why the renewed interest? Am J Kidney Dis 1998;32(suppl 4):76-82.
10. Gotch FA: The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998;13:10-14.
11. Clark WR, Leypoldt JK, Henderson LW, Sowinsik KM, Scott MK, Mueller BA, Vonesh EF: Effect of changes in dialytic frequency, duration and flow rates on solute kinetics and effective clearances (abstract). J Am Soc Nephrol 1997;8:280.
12. Fagugli RM, De Smet R, Buoncristiani U, Lameire N, Vanholder V: Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. Am J Kidney Dis 2002;40:339-347.
13. Floridi A, Antolini F, Galli F, Fagugli RM, Floridi E, Buoncristiani U: Daily hemodialysis improves indices of protein glycation. Nephrol Dial Transplant 2002;17:871-878.
14. Buoncristiani U, Quintaliani G, Cozzari M, Giobini LRM: Daily dialysis: long-term clinical metabolic results. Kidney Int 1988;24(suppl 24):137-140.
15. Ting G, Freitas T, Saum N, Carrie B, Kjellstrand C: Early metabolic, hematological, clinical and life quality changes with daily hemodialysis (abstract). Perit Dial Int 1998;18(suppl 1):78.
16. Kooistra MP, Vos J, Koomans HA, Vos PF: Daily home haemodialysis in the Netherlands: Effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 1998;13:2853-2860.
17. Woods JD, Port FK, Orzol S, Buoncristiani U, Young E, Wolfe RA, Held PJ: Clinical and biochemical correlates of starting 'daily' hemodialysis. Kidney Int 1999;55:2467-2476.
18. Quintaliani G, Buoncristiani U, Fagugli R, Kuluiranu H, Ciao G, Rondini L, Lowenthal DT, Reboldi G: Survival of vascular access during daily and three times a week hemodialysis. Clin Nephrol 2000;53:372-377.
19. Galland R, Traeger J, Arkouche W, Cleaud C, Deawari D, Fouque D: Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int 2001;60:1555-1560.
20. Galland R, Traeger J, Arkouche W, Delewari E, Fouque D: Short daily hemodialysis and nutritional status. Am J Kidney Dis 2001;37(suppl 2):95-98.
21. Lacson E, Diaz-Buxo JA: Daily and nocturnal hemodialysis: How do they stack up? Am J Kidney Dis 2001;38:225-239.
22. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U: Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001;38:371-376.
23. Pierratos A: Nocturnal home hemodialysis: An update on a 5-year experience. Nephrol Dial Transplant 1999;14:2835-2840.
24. 2-Microglobulin kinetics in nocturnal hemodialysis. Nephrol Dial Transplant 2000;15:58-64.
25. Musci I, Hercz G, Uldall R, Ouwendyk M, Frnacoeur R, Pierratos A: Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998;53:1399-1404.
26. Chan CT, Floras JS, Miller JA, Richardson RMA, Pierratos A: Regression of left ventricular hypertrophy after conversion to nocturnal dialysis. Kidney Int 2002;61:2235-2239.
27. Hörl MP, Hörl WH: Hypertension and dialysis. Kidney Blood Press Res 2003;26:76-81.
28. Hanly PJ, Pierratos A: Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001;344:102-107.